Global biopharmaceutical company UCB, which focuses on improving life for patients with severe immunological and neurological conditions, achieved a milestone in its digital transformation journey. The company innovated by teaming up with ZS to use the AI-enabled VERSO Field Insights to reinvent its sales targeting approach with dynamic targeting.  A key goal for this tool was to improve how UCB’s field employees connect with healthcare providers and help meet patient needs. And the success of this cross-functional initiative was recognized as the Most Valuable Data and Insights Initiative at the Reuters Pharma Awards USA 2020.

 

Here’s how UCB is driving digital transformation from concept to action by addressing the challenge of delivering better insights on the HCP’s customer journey. We outline what was unique about UCB’s approach and why the AI-driven initiative is making an impact.